Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

1.74
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
1.61
Today|||52-Week Range
14.70
-54.70%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close1.74
Today’s open1.74
Day’s range1.71 - 1.75
Volume97,530
Average volume (3 months)97,291
Market cap$27.2M
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...+0.35+5.04%
NVIVInVivo Therapeutics ...0.000.00%
HSGXHistogenics Corp0.000.00%
AZRXAzurRx BioPharma Inc0.000.00%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts